International Journal of Gynecologic Cancer: 15 (2)

REVIEW ARTICLE

Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer (1 February, 2005)
A. Du Bois, J. Rochon, C. Lamparter, J. Pfisterer
Accuracy of frozen-section analysis in the diagnosis of ovarian tumors: a systematic quantitative review (1 February, 2005)
L. R. Medeiros, D. D. Rosa, M. I. Edelweiss, A. T. Stein, M. C. Bozzetti, A. Zelmanowicz, P. R. Pohlmann, L. Meurer, M. T. Carballo
Understanding and treating depression among cancer patients (1 February, 2005)
R. K. Bailey, D. J. Geyen, K. Scott-Gurnell, M. M.S. Hipolito, T. A. Bailey, J. M. Beal

ORIGINAL ARTICLES

Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance (1 February, 2005)
H. T. See, R. S. Freedman, A. P. Kudelka, T. W. Burke, D. M. Gershenson, S. Tangjitgamol, J. J. Kavanagh
Neoadjuvant chemotherapy in advanced ovarian cancer: a case-control study (1 February, 2005)
V. Loizzi, G. Cormio, L. Resta, C. A. Rossi, A. R. Di Gilio, A. Cuccovillo, L. Selvaggi
Carboplatin hypersensitivity induced by low-dose paclitaxel/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer (1 February, 2005)
Y. Watanabe, H. Nakai, H. Ueda, K. Nozaki, H. Hoshiai
A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy (1 February, 2005)
S. ŞEHİRALİ, M. M. İNAL, S. ÖZSEZGİN, M. Sanci, Ö. Atli, C. Nayki, Y. Yildirim, Ş. Tinar
Intraperitoneal hyperthermic chemotherapy in ovarian cancer (1 February, 2005)
J. Gori, R. Castaño, M. Toziano, D. HÄBICH, J. Staringer, D. G.B. De Quirós, N. Felci
Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens (1 February, 2005)
R. Uslu, U. A. Sanli, Y. Dikmen, B. Karabulut, A. Ozsaran, C. Sezgin, G. G. Muezzinoglu, S. B. Omay, E. Goker
A novel early-stage orthotopic model for ovarian cancer in the Fischer 344 rat (1 February, 2005)
K. D. Sloan Stakleff, A. G. Rouse, A. P. Ryan, N. A. Haller, V. E. Von Gruenigen
Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival (1 February, 2005)
M. R. Raspollini, G. Amunni, A. Villanucci, V. Boddi, G. L. Taddei
Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization (1 February, 2005)
A. Fishman, E. Shalom-Paz, M. Fejgin, E. Gaber, M. Altaras, A. Amiel
Information given to women invited for cervical screening: results of two postal surveys seven years apart (1 February, 2005)
H. V. Duggal, B. Olowokure, M. Caswell, S. A. Wardle
Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer (1 February, 2005)
Y. S. Lin, C. C. Tzeng, K. F. Huang, C. Y. Kang, C. C. Chia, J. F. Hsieh
Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment (1 February, 2005)
K. Lindel, P. Burri, H. U. Studer, H. J. Altermatt, R. H. Greiner, G. Gruber
Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels (1 February, 2005)
K. MÜNSTEDT, P. Johnson, M. K. Bohlmann, M. Zygmunt, R. Von Georgi, H. Vahrson
Evaluation of cytologic screening results of the cervix (1 February, 2005)
S. Yalti, B. GÜRBÜZ, R. Bilgiç, Y. ÇAKAR, S. Eren
Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases (1 February, 2005)
S. Tsunoda, T. Jobo, M. Arai, M. Imai, T. Kanai, T. Tamura, J. Watanabe, A. Obokata, H. Kuramoto

BASIC SCIENCE

Antiproliferative activity and toxicity of 2-methoxyestradiol in cervical cancer xenograft mice (1 February, 2005)
L. Li, J. Da, M. Landström, U. Ulmsten, X. Fu
Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer (1 February, 2005)
A. Ercoli, G. Ferrandina, M. Genuardi, G. F. Zannoni, L. Cicchillitti, G. Raspaglio, S. Carrara, S. Mancuso, G. Scambia
Epstein–Barr virus plays little role in cervical carcinogenesis in Korean women (1 February, 2005)
S. S. Seo, W. H. Kim, Y. S. Song, S. H. Kim, J. W. Kim, N. H. Park, S. B. Kang, H. P. Lee
Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer (1 February, 2005)
A. Obermair, T. P. Manolitsas, Y. Leung, I. G. Hammond, A. J. Mccartney
Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy (1 February, 2005)
R. Machtinger, J. Korach, A. Padoa, E. Fridman, M. Zolti, J. Segal, Y. Yefet, M. Goldenberg, G. Ben-Baruch
Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma (1 February, 2005)
S. Arita, F. Kikkawa, H. Kajiyama, K. Shibata, M. Kawai, K. Mizuno, T. Nagasaka, K. Ino, S. Nomura
Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas (1 February, 2005)
G. Kir, H. Cetiner, A. Karateke, A. Gurbuz, D. Bulbul
Human telomerase RNA as endogenous control in endometrial tissue (1 February, 2005)
M. Paul-Samojedny, A. Witek, A. Samojedny, A. Witkowska, T. Wilczok
Differential regulation of protein kinase C activity by modulating factors and Euonymus alatus (Thunb.) Sieb in human myometrial and uterine leiomyomal smooth muscle cells
(1 February, 2005)
T.-K. Lee, J.-Y. Lee, D.-I. Kim, Y.-C. Lee, C.-H. Kim

CORRESPONDENCE AND BRIEF REPORTS

Steppe by steppe: gynecological oncology on the Mongolian plains (1 February, 2005)
L. Elit
Extrauterine müllerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature (1 February, 2005)
H.-Y. Chang, C.-C. Changchien, H.-H. Chen, H. Lin, C.-C. Huang
Villoglandular adenocarcinoma of the cervix recurrent in an episiotomy scar: a case report in a 32-year-old female (1 February, 2005)
D. E. Heron, A. Axtel, K. Gerszten, A. Amortegui, J. Kelley, J. Comerci, R. P. Edwards
A case with multiple gynecological malignancies (1 February, 2005)
B. O. Goker, T. Bese, S. Ilvan, E. Yilmaz, F. Demirkiran
Umbilical metastasis (Sister Joseph's nodule) as a first sign of a disseminated ovarian carcinoma: comparative immunohistochemical analysis of primary tumor and its metastases (1 February, 2005)
D. Brasanac, I. Boricic, V. Todorovic, G. Basta-Jovanovic
Immature ovarian teratoma in a young girl: very short course and lethal outcome. A case report (1 February, 2005)
M. Terzic, M. Dokic, B. Stimec
Placental site trophoblastic tumor presenting as subaponeurotic metastasis (1 February, 2005)
Y. Aoki, H. Kase, K. Kashima, T. Yahata, K. Tanaka

SURGEON'S CORNER

A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function (1 February, 2005)
N. Sakuragi, Y. Todo, M. Kudo, R. Yamamoto, T. Sato
Future challenges in clinical and translational research for endometrial cancer (1 February, 2005)
R. R. Broaddus, K. H. Lu

Session 1 – Screening, Prevention, and Early Disease

EARLY MOLECULAR CHANGES IN ENDOMETRIAL CANCER: 0001 (1 February, 2005)
L. H. Ellenson
LOSS OF CABLES IS ASSOCIATED WITH DEVELOPMENT OF ENDOMETRIAL HYPERPLASIA AND CANCER: 0002 (1 February, 2005)
B. R. Rueda, L. R. Zukerberg
ENDOMETRIAL CANCER IN WOMEN WITH HNPCC: 0003 (1 February, 2005)
K. Lu
ATYPICAL ENDOMETRIAL HYPERPLASIA: A TOUGH CALL (1 February, 2005)
C. L. Trimble
CONTROVERSIES IN THE MANAGEMENT OF ATYPICAL HYPERPLASIA: CONSERVATIVE MANAGEMENT VS. SIMPLE HYSTERECTOMY (1 February, 2005)
J. P. Curtin

Session 2 – Molecular, Clinical, and Pathologic Correlates of Endometrial Tumor Behavior

PREDICTORS OF POOR PROGNOSIS IN ENDOMETRIAL CANCER: 0006 (1 February, 2005)
A. Mariani, S. Dowdy, K. C. Podratz
MSI IN ENDOMETRIAL CANCER: PREVALENCE AND CLINICAL APPLICATIONS (1 February, 2005)
P. J. Goodfellow
EXPRESSION OF CANDIDATE BIOMARKERS IN ENDOMETRIAL HYPERPLASIA AND CANCERS: 0008 (1 February, 2005)
D. S. Loose, G. Shipley, P. J.A. Davies, A. McCampbell, L. Deng, R. Broaddus, K. Lu
ROLE OF GENE EXPRESSION PROFILING IN DISTINGUISHING BIOLOGICALLY AND CLINICALLY DISTINCT SUBCLASSES OF ENDOMETRIAL CARCINOMA: 0009 (1 February, 2005)
J. Boyd

Session 3 – Aggressive Forms of Endometrial Cancer – UPSC and MMMT

DIAGNOSTIC CHALLENGES IN PATHOLOGY: 0010 (1 February, 2005)
E. G. Silva
CpG ISLAND METHYLATION PATTERNS IN VARIOUS HISTOTYPES OF ENDOMETRIAL CANCER: 0011 (1 February, 2005)
R. R. Broaddus, S.-S. Xie, L. Ramondetta, J.-P. Issa, D. Loose
NOVEL STRATEGIES FOR THE MANAGEMENT OF UTERINE MALIGNANT MIXED MULLERIAN TUMORS: 0012 (1 February, 2005)
L. M. Ramondetta
WHAT IS THE CORRECT MANAGEMENT OF STAGE I UPSC?: 0013 (1 February, 2005)
W. K. Huh
ADVANCES IN THE MANAGEMENT OF ADVANCED AND RECURRENT UTERINE PAPILLARY SEROUS CARCINOMA: 0014 (1 February, 2005)
B. M. Slomovitz, J. Wolf, L. M. Ramondetta, T. W. Burke, K. H. Lu

Session 4 – Debates in the Clinical Management of Endometrial Cancer

IS LYMPHADENECTOMY REQUIRED FOR ALL PATIENTS WITH ENDOMETRIAL CANCER?: 0015 (1 February, 2005)
L. C. Kilgore
LAPAROSCOPICALLY ASSISTED SURGICAL STAGING FOR ENDOMETRIAL CANCER: 0016 (1 February, 2005)
R. R. Barakat
UPDATES IN CHEMOTHERAPY IN THE TREATMENT OF ADVANCED AND RECURRENT ENDOMETRIAL CANCER: 0017 (1 February, 2005)
D. S. McMeekin
THE ROLE OF RADIATION TREATMENT IN INTERMEDIATE RISK ENDOMETRIAL CANCER—PRO: 0018 (1 February, 2005)
Patricia J. Eifel
ROLE OF RADIATION TREATMENT IN INTERMEDIATE RISK ENDOMETRIAL CANCER—CON: 0019 (1 February, 2005)
T. W. Burke

Session 5 – Future Direction: Novel Therapeutic Strategies for Endometrial Cancer

TYROSINE KINASE INHIBITORS IN ENDOMETRIAL CANCER: 0020 (1 February, 2005)
K. K. Leslie, L. Laidler, L. Albitar, S. Davies, A. Holmes, T. Nguyen, J. Bolnick, D. Dai
NOVEL BIOLOGIC THERAPIES FOR THE TREATMENT OF ENDOMETRIAL CANCER: 0021 (1 February, 2005)
J. Wolf, B. M. Slomovitz

Main menu

Table of contents

February 2005 - Volume 15 - 2

REVIEW ARTICLE

ORIGINAL ARTICLES

BASIC SCIENCE

CORRESPONDENCE AND BRIEF REPORTS

SURGEON'S CORNER

Session 1 – Screening, Prevention, and Early Disease

Session 2 – Molecular, Clinical, and Pathologic Correlates of Endometrial Tumor Behavior

Session 3 – Aggressive Forms of Endometrial Cancer – UPSC and MMMT

Session 4 – Debates in the Clinical Management of Endometrial Cancer

Session 5 – Future Direction: Novel Therapeutic Strategies for Endometrial Cancer

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

February 2005 - Volume 15 - 2

REVIEW ARTICLE

ORIGINAL ARTICLES

BASIC SCIENCE

CORRESPONDENCE AND BRIEF REPORTS

SURGEON'S CORNER

Session 1 – Screening, Prevention, and Early Disease

Session 2 – Molecular, Clinical, and Pathologic Correlates of Endometrial Tumor Behavior

Session 3 – Aggressive Forms of Endometrial Cancer – UPSC and MMMT

Session 4 – Debates in the Clinical Management of Endometrial Cancer

Session 5 – Future Direction: Novel Therapeutic Strategies for Endometrial Cancer